Peter, agree with you 100%. Its been a long and difficult ride, esp watching KOOP hit $45 on the basis of an announcement to "spend" $90M for advertising. IMO, MCNS will continue to be the wall-flower, until another mega-deal is inked with a pharmaceutical or a deep-pocketed partner climbs aboard. Both are inevitable, question is when. Until then, keep in mind that MCNS continues to execute its business plan and grow the company. Many positives on the horizon:
1) Another acquisition to close soon
2) MCNS has expanded sales force and is actively working with the pharmaceuticals on new programs
3) MCNS face-lift to debut in August
4) $10M marketing blitz to launch this fall
5) Good healthy financials, no debt, a growing revenue stream and a very frugal and responsible mgmt team, holding the line on expenses --- should ensure profitability soon
6) Great traffic numbers and solid portfolio; very attractive assets given sector interest and consolidation
Markets are currently a mess ... remember MCNS touched $14 1/2 just weeks ago on the news of the Russell 2000 listing. Hopefully we'll recover soon. Until then, keep drinking heavily. Regards. DAVID |
